Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed. The five resolutions were:

Resolution 1: To re-elect Pip Greenwood as a Director.
Resolution 2: To authorise the Directors to fix the fees and expenses of the company’s auditor.
Resolution 3: To approve an increase in the maximum aggregate annual remuneration payable to non-executive Directors
Resolution 4: To approve the issue of performance share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2023.
Resolution 5: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2023.

All resolutions were decided by poll. The details of the total number of votes cast online, in person, via phone or by proxy on the polls were as follows:
 

Resolution	Votes For	Against	Abstain
Resolution 1: Re-election of Pip Greenwood	427,893,291 98.20%	7,834,272 1.80%	35,346
Resolution 2: Authorise Directors to fix fees and expenses of auditor	425,527,974 97.66%	10,194,972 2.34%	39,963
Resolution 3: Directors’ remuneration	360,396,312 82.93%	74,183,490 17.07%	97,679
Resolution 4: Issue of performance share rights to Lewis Gradon	425,084,178 97.62%	10,377,692 2.38%	299,289
Resolution 5: Issue of options to Lewis Gradon	421,626,407 96.83%	13,812,449 3.17%	322,303

 

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Media & Investor Contacts:

Hayden Brown Head of Capital Markets & Investor Relations hayden.brown@fphcare.co.nz +64 (0) 27 807 8073   Dan Adolph Senior Communications and Investor Relations Manager daniel.adolph@fphcare.co.nz +64 (0) 22 511 4050

Authorised by Raelene Leonard, General Counsel & Company Secretary.